 NHS Costs |
|||
|
|||
The Department of Health has published new guidance for funding excess treatment costs and subventions to clarify the directions set out in HSG(97)32. The guidance relates to non-commercial research studies eligible for entry onto the NIHR Clinical Research Network Portfolio database. Funding to cover these costs is allocated to PCTs as part of their overall revenue allocations however where the Excess Treatment Costs impacts unfairly on a very small number of NHS organisations and would risk services disruption to NHS services the chief investigator can apply for subvention. You can find details of the new guidance at: Further guidance on costs for NHS researchers is available on the Department of Health website:
|
|||
|
|||
The Efficacy and Mechanism Evaluation programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D, Public Health Agency in Northern Ireland. It is managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) based at the University of Southampton. |
 |
||
www.dh.gov.uk/en/PublicationsPolicyAndGuidance/DH_097628
printer friendly version
Share